Scientific ReportsPharmacology & ToxicologyPeer-reviewed journal article
Larval motility assay using WMicrotracker: a high throughput test to discriminate between resistance and susceptibility to anthelmintic drugs in nematodes
Mélanie AlberichiD, Marie Garcia, Julie PetermanniD, Clara BlancfuneyiD, Sophie JouffroyiD, Philippe JacquietiD, Anne LespineiD
Abstract
Grazing ruminants suffer from various helminth infections particularly those caused by gastrointestinal nematode (GIN) parasites, which have a considerable impact on their welfare and productivity. Treatment predominantly relies on macrocyclic lactone (ML) anthelmintics, but their widespread application has led to the emergence of drug-resistant parasite populations worldwide. The standard method for detecting resistance, the Faecal Egg Count Reduction Test (FECRT), is susceptible to misinterpretation, leading to flawed management decisions that undermine parasite control efforts. Thus, there is a pressing need for robust resistance detection methods in field parasites. We investigated the potential of the WMicrotrackerTM (WMi) motility assay, previously unexplored in ML resistance assessment. The assay first compared ivermectin (IVM) susceptibility among wild-type Bristol N2 (N2B), IVM-selected (IVR10), and nhr-8 loss-of-function (AE501; nhr8(ok186)) Caenorhabditis elegans strains. Dose-response curves indicated differences in IVM susceptibility among strains, with IVR10 exhibiting a 2.12-fold decrease in sensitivity compared to N2B. Cross-resistance between IVM, moxidectin (MOX), and eprinomectin (EPR) was explored, demonstrating reduced susceptibility in IVR10 across all drugs compared to N2B. Further investigation was conducted using Haemonchus contortus (H. contortus) to assess the assays applicability in discriminating susceptible from resistant isolates. Results revealed significant differences in drug potency between susceptible and resistant isolates, with MOX demonstrating the highest efficacy. Resistance factors (RF) highlighted the substantial resistance of the resistant isolate to EPR. The motility assay effectively discriminated susceptible from resistant isolates in both C. elegans and H. contortus. Our findings demonstrate, for the first time, the relevance of the motility assay by WMi as a functional indicator of resistance in nematodes, offering a promising avenue for detecting resistance to MLs. This research sheds light on a novel approach for monitoring drug resistance, vital for effective parasite management strategies.
- organism: C. elegans
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 11
- FWCI
- 7.96
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterising anthelmintic resistance against benzimidazoles and macrocyclic lactones in gastrointestinal nematode populations of dairy cattle
Paul Campbell, Jennifer McIntyre, … Roz Laing·bioRxiv·Sep 14, 2025
- Two novel loci underlie natural differences in Caenorhabditis elegans macrocyclic lactone responses
Kathryn S. Evans, Janneke Wit, … Erik C. Andersen·PLoS PathogensPeer-reviewed·Mar 15, 2021
- Discovery of anthelmintic small molecules in the Medicines for Malaria Ventures COVID and Global Health Priority Boxes using an infrared-based assay for Caenorhabditis elegans motility
C. Caffrey, L. Liu, Y. U. Sun·bioRxiv·Dec 9, 2023
- First evaluation and detection of ivermectin resistance in gastrointestinal nematodes of sheep and goats in South Darfur, Sudan
K. M. Mohammedsalih, A. I. Y. Ibrahim, … J. Krücken·bioRxiv·Mar 20, 2024
- The uptake of avermectins in Caenorhabditis elegans is dependent on Intra-Flagellar Transport and other protein trafficking pathways
R. A. Brinzer, D. J. France, … A. P. Page·bioRxiv·Oct 22, 2021
- Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans strains
Amanda O. Shaver, Janneke Wit, … Erik C. Andersen·PLoS PathogensPeer-reviewed·Apr 3, 2023